Molecular profiling of kenyan acute myeloid leukemia patients
M Gatua, M Navari, M Ong'ondi, N Onyango… - Frontiers in …, 2022 - frontiersin.org
Acute myeloid leukemia (AML) is an infrequent disease, and it is associated with high
morbidity and mortality. It harbors a unique configuration of cytogenetic abnormalities and …
morbidity and mortality. It harbors a unique configuration of cytogenetic abnormalities and …
Lower Levels of TET2 Gene Expression, with a Higher Level of TET2 Promoter Methylation in Patients with AML; Evidence for the Role of Aberrant Methylation in AML …
B Ghasemi, J Ahmadi, F Zaker, T Tabatabaei… - Indian Journal of …, 2024 - Springer
DNA methylation is a key epigenetic mechanism that is dysregulated in leukemia and plays
a significant role in leukemogenesis. Ten-eleven translocation 2 (TET2) is one of the most …
a significant role in leukemogenesis. Ten-eleven translocation 2 (TET2) is one of the most …
[PDF][PDF] Ten Eleven Translocation Gene 2 (TET2) polymorphism in acute myeloid leukemia
AMN Hamed, AA Nazer, MW Ayad, TS Sadiq - Ann Adv Med Sci, 2018 - researchgate.net
Background: Acute myeloid leukemia (AML) is a genetically heterogeneous disease in
which somatic mutations that disturb cellular growth, proliferation, and differentiation …
which somatic mutations that disturb cellular growth, proliferation, and differentiation …
TET2 Single Nucleotide Polymorphism in Myeloid Neoplasms Among Egyptian Patients
EA Dammag, NAM Hamed, NA Elhalawani… - Indian Journal of …, 2020 - Springer
Acute myelogenous leukemia (AML) is a heterogeneous disease characterized by myeloid
progenitor cells uncontrolled proliferation gradually replacing normal hematopoiesis. To …
progenitor cells uncontrolled proliferation gradually replacing normal hematopoiesis. To …
Impact of DNMT3A Gene Mutation on Response of Acute Myeloid Leukemia Patients to Induction Therapy
DG Segai, N Ramsis, H Fahmy… - … Blood Research & …, 2018 - asian.universityeprint.com
Aim: To evaluate the frequency and prognostic impact of DNA methyltransferase 3A
(DNMT3A) gene mutation on response to induction therapy in newly diagnosed acute …
(DNMT3A) gene mutation on response to induction therapy in newly diagnosed acute …